All Posts By

admin

Orphalan announces European Medicines Agency (EMA) acceptance for review of Marketing Authorization Application (MAA) for KIZFIZO® Actualités de l’entreprise

Orphalan announces European Medicines Agency (EMA) acceptance for review of Marketing Authorization Application (MAA) for KIZFIZO®

Marketing Authorization Application for KIZFIZO® accepted for review by the EMA for the treatment of malignant glioma London, UK, March 30, 2026 – Orphalan, a pharmaceutical company dedicated to the…
mars 30, 2026
Orphalan, spécialisée dans le développement et la commercialisation de médicaments orphelins, annonce l’acquisition d’Orphelia Pharma Communiqué de presse

Orphalan, spécialisée dans le développement et la commercialisation de médicaments orphelins, annonce l’acquisition d’Orphelia Pharma

Orphalan, entreprise pharmaceutique internationale spécialisée dans le développement et la commercialisation de médicaments orphelins, annonce l'acquisition d'Orphelia Pharma, société pharmaceutique française dédiée aux maladies pédiatriques rares et graves dans les…
novembre 27, 2025
Orphalan Partners with MAP International and the Wilson Disease Association to Provide Life-Changing Medicine to Underserved Communities Communiqué de presse

Orphalan Partners with MAP International and the Wilson Disease Association to Provide Life-Changing Medicine to Underserved Communities

Paris, France —27, June, 2025— Orphalan SA, a global pharmaceutical company focused on rare diseases, is partnering with MAP International and the Wilson Disease Association (WDA) to provide Cuvrior® (trientine…
juin 27, 2025
Orphalan announces China NMPA’s approval of its trientine tetrahydrochloride product for the treatment of Wilson disease Actualités de l’entrepriseCommuniqué de presse

Orphalan announces China NMPA’s approval of its trientine tetrahydrochloride product for the treatment of Wilson disease

Paris, France 18 January, 2024 – Orphalan SA (“Orphalan” or “the Company”), an international orphan drug development and commercialization company, today announces the approval of its trientine tetrahydrochloride product by China’s…
janvier 18, 2024
Podcast: Naseem Amin, Orphalan CEO, discusses Wilson’s Disease and the potential advancements in its treatments on DNA Today Actualités de l’entreprise

Podcast: Naseem Amin, Orphalan CEO, discusses Wilson’s Disease and the potential advancements in its treatments on DNA Today

DNA Today is a multi-award-winning podcast and radio show exploring how genetics impacts our health. Host/Producer Kira Dineen interviews leaders in genetics including genetic counsellors, researchers, physicians, and patient advocates…
février 6, 2023